Fear of cancer recurrence and mental health: A comprehensive meta-analysis.

anxiety cancer cancer survivors depression distress fear of cancer progression fear of cancer recurrence mental health oncology

Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
Oct 2023
Historique:
revised: 28 07 2023
received: 27 01 2023
accepted: 06 08 2023
pubmed: 19 8 2023
medline: 19 8 2023
entrez: 19 8 2023
Statut: ppublish

Résumé

This study aimed to examine the relationship between fear of cancer recurrence (FCR) and symptoms of anxiety, depression, and emotional distress in cancer survivors. Additionally, potential effect modifiers of this link were investigated. A systematic search was conducted in PsychInfo, PubMed/Medline, Web of Science, and the Cochrane Central Register of Controlled Trials until June 2022. Studies reporting the association between FCR and mental health indices in adolescent and young adult survivors (15-39 years) and adult survivors (>18 years) were included. Study quality was assessed using the Joanna Briggs Institute checklist for cross-sectional studies. A total of 72 primary studies with 31,740 participants were identified, with the majority having a low risk of bias. The results revealed a significant association between FCR and depression, anxiety, and emotional distress. This association was observed whether FCR was examined in relation to each factor individually or collectively. The effect sizes fell within the medium range. Notably, the relationship between FCR and mental health strengthened over the years of publication. Additionally, lengthier FCR assessment instruments yielded larger effect sizes compared to shorter and single-item instruments, underscoring the significance of instrument selection. This meta-analysis provides further evidence that FCR is linked to a range of common mental health problems. The medium effect sizes observed indicate the need to consider FCR when evaluating the mental health of cancer survivors, and vice versa. Further research is required to elucidate the underlying mechanisms of the FCR-mental health link.

Identifiants

pubmed: 37596855
doi: 10.1002/pon.6205
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1503-1513

Subventions

Organisme : This work was supported by a grant of the Romanian Ministry of Education and Research, CNCS-UEFISCDI, project number PN-III-P1-1.1-TE-2019-2140, within PNCDI III

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660
Tauber NM, O’Toole MS, Dinkel A, et al. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis. J Clin Oncol. 2019;37(31):2899-2915. https://doi.org/10.1200/jco.19.00572
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA A Cancer J Clin. 2022;72(1):7-33. Wiley Online Library. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21708
Herschbach P, Dinkel A. Fear of progression. In: Goerling U, ed. Psycho-Oncology. Springer; 2014:11-29. https://doi.org/10.1007/978-3-642-40187-9_2
Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24(8):3265-3268. https://doi.org/10.1007/s00520-016-3272-5
Costa DSJ. Screening for clinical levels of fear of cancer recurrence. Psycho Oncol. 2017;26(11):2002-2003. https://doi.org/10.1002/pon.4390
Bisseling EM, Compen FR, Schellekens MPJ, Thewes B, Speckens AEM, van der Lee ML. Exploring fear of cancer recurrence in a sample of heterogeneous distressed cancer patients with and without a psychiatric disorder. J Clin Psychol Med Settings. 2021;28(3):419-426. https://doi.org/10.1007/s10880-021-09776-2
Luigjes-Huizer YL, Tauber NM, Humphris G, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho Oncol. 2022;31(6):879-892. https://doi.org/10.1002/pon.5921
Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(31):3540-3546. https://doi.org/10.1200/jco.2014.56.0086
Brandenbarg D, Maass SWMC, Geerse OP, et al. A systematic review on the prevalence of symptoms of depression, anxiety and distress in long-term cancer survivors: implications for primary care. Eur J Cancer Care. 2019;28(3):e13086. https://doi.org/10.1111/ecc.13086
Fodor LA, Todea D, Podina IR. Core fear of cancer recurrence symptoms in cancer survivors: a network approach. Curr Psychol. 2022. https://doi.org/10.1007/s12144-022-03500-5
Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2021;45(5):406-415. https://doi.org/10.1097/ncc.0000000000001020
Sterne JAC, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119-1129. https://doi.org/10.1016/s0895-4356(00)00242-0
Zhang X, Sun D, Qin N, Liu M, Jiang N, Li X. Factors correlated with fear of cancer recurrence in cancer survivors: a meta-analysis. Cancer Nurs. 2022;45(5):406-415. https://doi.org/10.1097/ncc.0000000000001020
Lim E, Humphris G. The relationship between fears of cancer recurrence and patient age: a systematic review and meta-analysis. Cancer Rep. 2020;3:e1235. https://doi.org/10.1002/cnr2.1235
Pang C, Humphris G. The relationship between fears of cancer recurrence and patient gender: a systematic review and meta-analysis. Front Psychol. 2021;12. https://doi.org/10.3389/fpsyg.2021.640866
Yang Y, Wen Y, Bedi C, Humphris G. The relationship between cancer patient’s fear of recurrence and chemotherapy: a systematic review and meta-analysis. J Psychosom Res. 2017;98:55-63. https://doi.org/10.1016/j.jpsychores.2017.05.002
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho Oncol. 2013;22(5):978-986. https://doi.org/10.1002/pon.3114
O’Rourke L, Fisher PL, Campbell S, Wright A, Cherry MG. Factors associated with fear of cancer recurrence in family caregivers of cancer survivors: a systematic review. Front Psychol. 2021;12. https://doi.org/10.3389/fpsyg.2021.625654
Maguire R, Kotronoulas G, Simpson M, Paterson C. A systematic review of the supportive care needs of women living with and beyond cervical cancer. Gynecol Oncol. 2015;136(3):478-490. https://doi.org/10.1016/j.ygyno.2014.10.030
Chien C-H, Chuang CK, Liu KL, Wu CT, Pang ST, Chang YH. Positive and negative affect and prostate cancer-specific anxiety in Taiwanese patients and their partners. Eur J Oncol Nurs. 2018;37:1-11. https://doi.org/10.1016/j.ejon.2018.09.004
Thewes B, Kaal SEJ, Custers JAE, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer. 2018;26:1479-1487.
Vickberg SMJ. The Concerns about Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med Publ Soc Behav Med. 2003;25(1):16-24. https://doi.org/10.1207/s15324796abm2501_03
Best AL, Alcaraz KI, McQueen A, Cooper DL, Warren RC, Stein K. Examining the mediating role of cancer-related problems on spirituality and self-rated health among African American cancer survivors: a report from the American Cancer Society’s Studies of Cancer Survivors-II. Psycho Oncol. 2015;24(9):1051-1059. https://doi.org/10.1002/pon.3720
Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2019;17(10). https://jnccn.org/view/journals/jnccn/17/10/article-p1229.xml
Hall DL, Jimenez RB, Perez GK, et al. Fear of cancer recurrence: a model examination of physical symptoms, emotional distress, and health behavior change. J Oncol Pract. 2019;15(9):e787-e797. https://doi.org/10.1200/jop.18.00787
van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psycho Oncol. 2008;17(11):1137-1145. https://doi.org/10.1002/pon.1340
Kim Y, Carver CS, Spillers RL, Love-Ghaffari M, Kaw CK. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res. 2012;21(3):517-525. https://doi.org/10.1007/s11136-011-9953-0
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132-140. https://doi.org/10.1097/xeb.0000000000000055
Statistical Software for Data Science | Stata. https://www.stata.com/
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. John Wiley & Sons; 2021.
Peterson RA, Brown SP. On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005;90(1):175-181. https://doi.org/10.1037/0021-9010.90.1.175
Orsini N, Bottai M, Higgins J, Buchan I. HETEROGI: Stata Module to Quantify Heterogeneity in a Meta-Analysis; 2006.
Cuijpers P. Meta-analyses in Mental Health Research: A Practical Guide; 2016.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. https://doi.org/10.1136/bmj.315.7109.629
Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300-322. https://doi.org/10.1007/s11764-013-0272-z

Auteurs

Ioana R Podina (IR)

Laboratory of Cognitive Clinical Sciences, University of Bucharest, Bucharest, Romania.

Diana Todea (D)

Interdisciplinary School of Doctoral Studies, University of Bucharest, Bucharest, Romania.

Liviu-Andrei Fodor (LA)

International Institute for the Advanced Studies of Psychotherapy and Applied Mental Health, Babeș-Bolyai University, Cluj-Napoca, Romania.

Classifications MeSH